Enzolytics (ENZC) News Today → Will this $2 AI stock double overnight? (From Behind the Markets) (Ad) Free ENZC Stock Alerts $0.0043 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineEnzolytics, Inc. (ENZC)finance.yahoo.com - April 19 at 8:37 PMEnzolytics, Inc.: Update on Formulation of New Business Strategyfinanznachrichten.de - April 12 at 10:26 AMENZOLYTICS, INC. SHAREHOLDERS HOLD SPECIAL MEETING AND ELECT NEW BOARDfinance.yahoo.com - March 25 at 12:38 PMEnzolytics Stock (OTC:ENZC) Insider Tradesbenzinga.com - February 26 at 9:57 AMEnzolytics Stock (OTC:ENZC) Earnings Dates and Earning Callsbenzinga.com - February 22 at 2:42 PMEnzolytics, Inc. Announces Partnership With the Khalpey AI Lab To Forge the Future of Multi-Organ Remodeling and Rejuvenation With a Strategic Focus on Longevityfinance.yahoo.com - January 16 at 10:16 AMEnzolytics Inc ENZCmorningstar.com - November 11 at 8:02 AM"Exploring Penny Stocks: Four Watchlist Options" FTRS, ELTP, ENZC, ZOMbenzinga.com - October 31 at 7:36 AMEnzolytics Announces the Signing of the Business Combination Agreement with Sagaliam Acquisition Corp (SAGA)finance.yahoo.com - September 18 at 10:05 AMPatient Population for the Clinical Trials of ITV-1 has been Established by the European Medicines Agency ("EMA")finance.yahoo.com - September 6 at 5:10 PMBiogenysis, Inc. Announces Partnering with Khalpey AI Lab and Contenta, Ltd. to Incorporate AI in Microbiome Analysis to Identify Biomarkers for Use in Accurately Predicting Alzheimer's Disease Onset and Prevention.finance.yahoo.com - September 5 at 6:07 PMBiogenysis’ International Patent Application, Covering Its Anti-SARS-CoV-2 Monoclonal Antibodies, Advances to Prosecution in Europe and as a U.S. National Stage Application.finance.yahoo.com - August 24 at 9:38 AMVirogentics, Inc. Receives Permit for Export to Africa of the ITV-1 Immunotherapy Solidifying the Scheduled Administration of the Treatmentfinance.yahoo.com - August 8 at 2:25 PMVirogentics, Inc. Provides Update on African Project, European Medicine Agency Application and Clinical Trials for Application for Type 2 Diabetesfinance.yahoo.com - August 4 at 4:08 PMOTC Stocks to Watch in August 2023: HNRC, BDPT, ENZC, AABB, SNNCbenzinga.com - July 28 at 10:56 PMEnzolytics, Inc.: Virogentics Announces Approval of Final Protocol from the Dept for HIV and AIDS, Ministry of Health of the DRCfinanznachrichten.de - July 25 at 8:13 AMBiogenysis Inc. Announces a Collaboration with Khalpey AI Lab in using Artificial Intelligence (AI) for Unveiling Potential Biomarkers and Predicting the Onset or Prevention of Alzheimer's Disease.finance.yahoo.com - July 21 at 9:29 AMEnzolytics, Inc.: Virogentics, Inc to Introduce a Dietary Supplement Offers Additional Information on ITV-1 And Diabetic Clinical Trialsfinanznachrichten.de - July 6 at 1:58 PMVirogentics, Inc to Introduce a Dietary Supplement Offers Additional Information on ITV-1 And Diabetic Clinical Trialsfinance.yahoo.com - July 6 at 1:58 PMEnzolytics Offers Update on Virogentics, Inc ITV-1 African Projectfinance.yahoo.com - June 26 at 12:13 PMENZC - Enzolytics, Inc.sg.finance.yahoo.com - June 11 at 12:05 AMEnzolytics Offers Update on Virogentics and Sale Transaction, Clinical Trials Progress on European Medicine Agency (EMA) Permitting and Arican ITV-1 Projectfinance.yahoo.com - June 5 at 10:20 AMVirogentics and Enzolytics Refute Misleading Information Being Circulated on Social Media and Other Internet Outlets Biogenesis to be Featured in June Issue of Life Science Reviewfinance.yahoo.com - May 19 at 10:01 AMEnzolytics, Inc.: Virogentics Inc. Receives Report from Bulgarian Academy of Sciences Administration of ITV-1 to Begin First Week in June 2023finanznachrichten.de - May 16 at 10:34 AMVirogentics Inc. Receives Report from Bulgarian Academy of Sciences Administration of ITV-1 to Begin First Week in June 2023finance.yahoo.com - May 16 at 10:34 AMOTC Stocks Making Waves: Recent Developments and Potential Opportunities (HBRM, BBRW, ENZC, SIRC)benzinga.com - May 12 at 8:09 AMVirogentics Inc. Announces Pilot Clinical Trial of ITV-1 at National Center for Endocrinology in Bulgaria and Expansion of Nutraceutical Linefinance.yahoo.com - May 8 at 12:37 PMEnzolytics Inc. Continues Progress with Business Combination; Biogenysis Announces Team and Plans for Successfinance.yahoo.com - April 27 at 10:10 AMEnzolytics, Inc. Finalizing Regulatory Labeling Requirements for Delivery of ITV-1 Treatments for Use in Hospitals in Central and Eastern Africa - Company also Provides Additional Details on the Sale of Biogenysis and Virogenticsfinance.yahoo.com - April 21 at 8:52 AMEnzolytics Inc. (ENZC)ca.finance.yahoo.com - April 18 at 8:10 PMEnzolytics, Inc. Announces Execution of Non-Binding Term Sheet with the Special Purpose Acquisition Company Sagaliam Acquisition Corp. and Updates the Progress on the African Projectfinance.yahoo.com - April 17 at 7:55 AMEnzolytics Announces Progress in the Development and Patenting of Feline Leukemia Monoclonal Antibodiesfinance.yahoo.com - April 4 at 9:12 AMEnzolytics Stock (OTC:ENZC), Dividendsbenzinga.com - March 3 at 9:44 PMEnzolytics, Inc. Highlights Plans for Promotion of IPF Immune(TM), Its Patented Nutraceutical Supplementfinance.yahoo.com - February 28 at 8:46 AMEnzolytics Announces Preliminary Results of GLP Toxicology Study for its anti-HIV Therapeutic ITV-1 and Production of ITV-1 for Initiation of Registration in Africafinance.yahoo.com - February 8 at 8:33 AMEnzolytics to Develop Feline Monoclonal Antibodiesfinance.yahoo.com - January 3 at 9:28 AMEnzolytics, Inc. Announces the Completion of the 2020 and 2021 Audited Financialsfinance.yahoo.com - December 19 at 9:28 AMEnzolytics Recognizes World AIDS Day and Highlights the Company's Focus on Producing Effective Therapies for Treating HIVfinance.yahoo.com - December 1 at 6:57 AMEnzolytics, Inc. Announces Expansion of Production of Its Monoclonal Antibody Therapeutics and Marketing of IPF Immune(TM)finance.yahoo.com - November 16 at 8:09 PMEnzolytics Reports Successful Completion of an MTD Tolerability Study of Its ITV-1 anti-HIV Therapeutic Leading to the Start of a 28-day GLP Toxicology Studyfinance.yahoo.com - October 5 at 10:11 AMEnzolytics Inc. Announces Collaboration with Abveris to Discover Monoclonal Antibodiesfinance.yahoo.com - September 16 at 7:32 AMEnzolytics Inc. Announces Litigation Success, Accounting Progress and Removal of "Yield" Sign on OTC Markets Stock Quotesfinance.yahoo.com - September 14 at 10:11 AMENZC.PK - Enzolytics Inc | Stock Price & Latest News | Reutersreuters.com - August 14 at 9:03 PMEnzolytics Announces the International Patent Office Search Report finding Novelty and Inventiveness in the Company's Pending International Patent Application Covering its anti-HIV Monoclonal Antibodies.finance.yahoo.com - July 28 at 10:20 AM2022-06-21 | OTCPK:ENZC | Press Release | Enzolytics Inc - Stockhousestockhouse.com - June 21 at 3:32 PMEnzolytics Announces the Discovery of Conserved Target Sites on the Monkeypox Virusfinance.yahoo.com - June 21 at 10:32 AM2022-05-16 | OTCPK:ENZC | Press Release | Enzolytics Inc - Stockhousestockhouse.com - May 17 at 11:24 PMEnzolytics, Inc. Discusses the Significance and Revenue Potential of Its Therapeutic Platforms with The Stock Day Podcastfinance.yahoo.com - May 16 at 9:18 AMCORRECTION: Enzolytics, Inc. Reports Progress and Future Plansfinanznachrichten.de - April 25 at 3:23 PMEnzolytics, Inc.: Enzolytics IPF Immune Introduced to Large and Small Retail Buyers at Recent ECRM "Weight Management, Nutrition, and Vitamin Program"finanznachrichten.de - April 11 at 9:58 AM Get Enzolytics News Delivered to You Automatically Sign up to receive the latest news and ratings for ENZC and its competitors with MarketBeat's FREE daily newsletter. Email Address Will this $2 AI stock double overnight? (Ad)It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share! Click here to learn more >>> ENZC Media Mentions By Week ENZC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ENZC News Sentiment▼0.000.44▲Average Medical News Sentiment ENZC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ENZC Articles This Week▼10▲ENZC Articles Average Week Get Enzolytics News Delivered to You Automatically Sign up to receive the latest news and ratings for ENZC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Algernon Pharmaceuticals News ALK-Abelló A/S News Alpha Tau Medical News Arno Therapeutics News Artelo Biosciences News Ascletis Pharma News Awakn Life Sciences News AXIM Biotechnologies News BerGenBio ASA News BriaCell Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:ENZC) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American Alternative1970’s computer coder issues shocking A.I. warningTradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enzolytics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
